MakeMyTrip Hit By Short Seller Morpheus Research Report Alleging Regulatory Violations, Accounting Concerns

3/30/2026
Impact: -80
Consumer Cyclical

MakeMyTrip Ltd (NASDAQ: MMYT) is facing scrutiny following a report by Morpheus Research, which alleges regulatory violations, accounting concerns, and market share erosion. The report claims the company continues to enforce 'price parity' clauses despite a 2022 order from the Competition Commission of India to cease this practice. Additionally, it highlights a $20 million receivable from the insolvent Go Air and a $212 million discrepancy between adjusted profits and IFRS figures. As a result, MakeMyTrip's stock price fell 0.33% to $36.21 on Monday.

AI summary, not financial advice

Share: